-
Product Insights
H L Hutchinson – Wisbech Enterprise Park – Cambridgeshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our H L Hutchinson - Wisbech Enterprise Park - Cambridgeshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Georgia Ports – Hutchinson Island Port Expansion – Georgia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Georgia Ports - Hutchinson Island Port Expansion - Georgia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Edgewater Beach – Hutchinson Island Timeshare Resort Development – Georgia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Edgewater Beach - Hutchinson Island Timeshare Resort Development - Georgia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
GITC – Hutchinson Island Convention Center Hotel Development – Georgia
Equip yourself with the essential tools needed to make informed and profitable decisions with our GITC - Hutchinson Island Convention Center Hotel Development - Georgia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Sector Analysis
Indonesia Telecom Operators Country Intelligence Report
Indonesia Telecom Operators Country Intelligence Report The Indonesia telecom services market size was valued at $12.9 billion in 2022 and is expected to grow at a CAGR of more than 1% during the forecast period, 2022-2027. This growth will be driven by ongoing investments in 4G/ 5G network expansion and development by major operators and subsequent rise in mobile data usage, and investments in ICT and telecom infrastructure to accelerate digital transformation in the country. Indonesia Telecom Services Market Outlook,...
-
43% off
ASEAN Telecom Operators Country Intelligence Report Bundle
ASEAN Telecom Operators Country Intelligence Report Bundle The future of the telecom industry is about to heavily invest in 5G, impacting the top line of the industry. Along with 5G handset sales, 4G adoption will also see a peak and a rise in jobs in the mobile ecosystem. As a part of this bundle, you will gain access to in-depth insights available in the following reports: Indonesia Telecom Operators Country Intelligence Report Malaysia Telecom Operators Country Intelligence Report Philippines Telecom...
-
Company Profile
BeyondSpring Inc – Company Profile
BeyondSpring Inc (BeyondSpring) is a clinical-stage biopharmaceutical company that develops immune-oncology cancer therapies. The company's lead product candidate is Plinabulin, a selective immunomodulating microtubule-binding agent with potential chemotherapy-induced neutropenia (CIN) prevention and anti-cancer benefits. BeyondSpring other pipeline includes BPI-002, BPI-003 and BPI-004 for the treatment of various cancers and tumors. The company collaborates with Fred Hutchinson Cancer Center, University of California San Diego, Johns Hopkins University, Rutgers University and the University of Basel, among others. It operates through subsidiaries in...
Add to Basket -
Company Profile
Cullinan Oncology Inc – Company Profile
Cullinan Oncology Inc (Cullinan Oncology) clinical-stage biotechnology company. It focuses on the discovery and development of oncology therapies. Its product pipeline includes CLN-081 for the treatment of non-small cell lung cancer; CLN-619 against pan-cancer; and CLN-049 to treat relapsed and refractory acute myelogenous leukemia (AML), and myelodysplastic syndrome (MDS). Cullinan Oncology’s pipeline also includes drug programs such as CLN-418 for multiple solid tumors; CLN-978 to treat B-cell non-Hodgkin lymphomas; and CLN-617 for treatment of pan-cancer. The company also provides various...
Add to Basket -
Company Profile
Hutchinson SA – Company Profile
Hutchinson SA (Hutchinson), a subsidiary of Total SA, is a provider of customized materials and integrated solutions. It produces and sells body sealing systems, vibration control systems, fluid management systems, precision control systems, materials and structures and belt drive systems. The company’s product portfolio comprises car body sealing systems, door closures, door slides, door seals, structural and bodywork parts, beams, bumper protectors, side skirts, front and rear spoilers, fenders, and side bodywork. It also offers embedded electronic equipment, belt drives,...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRGS-1
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PRGS-1 Drug Details PRGS-1 (progerinin) is under development for the treatment of Hutchinson-Gilford progeria...